Jury orders Gilead’s Kite Pharma to pay $752M for CAR-T patent infringement – FiercePharma

0
264
Jury orders Gilead’s Kite Pharma to pay $752M for CAR-T patent infringement – FiercePharma

In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers Squibb and Gilead Sciences, BMS has come up with a victory. After a two-week trial, jurors in California ordered Gilead’s Kite Pharma to pay $752 million to BMS’ Juno Therapeutics and its p…
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here